These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 629799)

  • 1. Effect of oxygen concentration on the reaction of halothane with cytochrome P450 in liver microsomes and isolated perfused rat liver.
    Nastainczyk W; Ullrich V
    Biochem Pharmacol; 1978 Feb; 27(4):387-92. PubMed ID: 629799
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic activation of halothane and its covalent binding to liver endoplasmic proteins in vitro.
    Uehleke H; Hellmer KH; Tabarelli-Poplawski S
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 279(1):39-52. PubMed ID: 4147966
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxygen concentrations required for reductive defluorination of halothane by rat hepatic microsomes.
    Lind RC; Gandolfi AJ; Sipes IG; Brown BR; Waters SJ
    Anesth Analg; 1986 Aug; 65(8):835-9. PubMed ID: 3729018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reductive metabolism of halothane by cytochrome P450 isoforms in rats and humans.
    Chow T; Imaoka S; Hiroi T; Funae Y
    Res Commun Mol Pathol Pharmacol; 1996 Sep; 93(3):363-74. PubMed ID: 8896047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the stability and cytochrome P450 specificity of the phenobarbital-induced reductive halothane-cytochrome P450 complex formed in rat hepatic microsomes.
    Baker MT; Vasquez MT; Chiang CK
    Biochem Pharmacol; 1991 Jun; 41(11):1691-9. PubMed ID: 2043158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of reductive dehalogenation of halothane by liver cytochrome P450.
    Ahr HJ; King LJ; Nastainczyk W; Ullrich V
    Biochem Pharmacol; 1982 Feb; 31(3):383-90. PubMed ID: 7073765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoflurane acts as an inhibitor of oxidative dehalogenation while acting as an accelerator of reductive dehalogenation of halothane in guinea pig liver microsomes.
    Fujii K
    Toxicology; 1995 Dec; 104(1-3):123-8. PubMed ID: 8560490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The release of inorganic fluoride from halothane and halothane metabolites by cytochrome P-450, hemin, and hemoglobin.
    Baker MT; Nelson RM; Van Dyke RA
    Drug Metab Dispos; 1983; 11(4):308-11. PubMed ID: 6137335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human halothane reduction in vitro by cytochrome P450 2A6 and 3A4: identification of low and high KM isoforms.
    Spracklin DK; Kharasch ED
    Drug Metab Dispos; 1998 Jun; 26(6):605-7. PubMed ID: 9616199
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of reactive intermediates in halothane associated liver injury.
    Sipes IG; Gandolfi AJ
    Adv Exp Med Biol; 1981; 136 Pt A():603-18. PubMed ID: 7344482
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibitory effect of paraquat on biotransformation of halothane in rabbit liver microsomes.
    Kawamoto M; Fujii K; Yuge O; Morio M
    Hiroshima J Med Sci; 1989 Dec; 38(4):161-7. PubMed ID: 2637243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Halothane hepatotoxicity: relation between metabolic activation, hypoxia, covalent binding, lipid peroxidation and liver cell damage.
    de Groot H; Noll T
    Hepatology; 1983; 3(4):601-6. PubMed ID: 6345332
    [No Abstract]   [Full Text] [Related]  

  • 13. Resonance Raman study of the cytochrome P-450 LM2-halothane intermediate complex.
    Hildebrandt P; Garda H; Stier A; Stockburger M; Van Dyke RA
    FEBS Lett; 1988 Sep; 237(1-2):15-20. PubMed ID: 3169235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of halothane binding to microsomal cytochrome P450.
    Mansuy D; Nastainczyk W; Ullrich V
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(4):315-24. PubMed ID: 4280521
    [No Abstract]   [Full Text] [Related]  

  • 15. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
    Spracklin DK; Thummel KE; Kharasch ED
    Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulatory effects of halothane and isoflurane on fluoride release and cytochrome P-450 loss caused by metabolism of 2-chloro-1,1-difluoroethene, a halothane metabolite.
    Baker MT; Bates JN; Leff SV
    Anesth Analg; 1987 Nov; 66(11):1141-7. PubMed ID: 2889401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of radioactivity from 14 C-labeled halothane in isolated perfused rat livers.
    Van Dyke RA; Wood CL
    Anesthesiology; 1973 Apr; 38(4):328-32. PubMed ID: 4145288
    [No Abstract]   [Full Text] [Related]  

  • 18. The reduction of polyhalogenated methanes by liver microsomal cytochrome P450.
    Wolf CR; Mansuy D; Nastainczyk W; Deutschmann G; Ullrich V
    Mol Pharmacol; 1977 Jul; 13(4):698-705. PubMed ID: 18662
    [No Abstract]   [Full Text] [Related]  

  • 19. Reductive metabolism of halothane by human and rabbit cytochrome P-450. Binding of 1-chloro-2,2,2-trifluoroethyl radical to phospholipids.
    Trudell JR; Bösterling B; Trevor AJ
    Mol Pharmacol; 1982 May; 21(3):710-7. PubMed ID: 7110119
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of halothane oxidation by hepatic microsomes and purified cytochromes P-450 using a gas chromatographic mass spectrometric assay.
    Gruenke LD; Konopka K; Koop DR; Waskell LA
    J Pharmacol Exp Ther; 1988 Aug; 246(2):454-9. PubMed ID: 3404442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.